IL4I1 and neoplasm: Furthermore, the IL4I1/IDO1/AHR axis promotes tumor progression and aggressiveness [26–30] which is consistent with our Gene Set Enrichment Analysis (GSEA) indicating that mutant Δ133p53α R273H overexpression correlates with tumorigenic hallmarks (Fig. S1M).